Literature DB >> 28889094

Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation.

Oriol Dols-Icardo1,2, Alberto García-Redondo3,4, Ricardo Rojas-García4,5, Daniel Borrego-Hernández3, Ignacio Illán-Gala1,2, José Luís Muñoz-Blanco6, Alberto Rábano7, Laura Cervera-Carles1,2, Alexandra Juárez-Rufián3,4, Nino Spataro8,9, Noemí De Luna4,5, Lucía Galán10, Elena Cortes-Vicente5, Juan Fortea1,2, Rafael Blesa1,2, Oriol Grau-Rivera11,12, Alberto Lleó1,2, Jesús Esteban-Pérez3,4, Ellen Gelpi11, Jordi Clarimón1,2.   

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are part of a clinical, pathological and genetic continuum.
OBJECTIVES: The purpose of the present study was to assess the mutation burden that is present in patients with concurrent ALS and FTD (ALS/FTD) not carrying the chromosome 9 open reading frame 72 (C9orf72) hexanucleotide repeat expansion, the most important genetic cause in both diseases.
METHODS: From an initial group of 973 patients with ALS, we retrospectively selected those patients fulfilling diagnostic criteria of concomitant ALS and FTD lacking the repeat expansion mutation in C9orf72. Our final study group consisted of 54 patients clinically diagnosed with ALS/FTD (16 with available postmortem neuropathological diagnosis). Data from whole exome sequencing were used to screen for mutations in known ALS and/or FTD genes.
RESULTS: We identified 11 patients carrying a probable pathogenic mutation, representing an overall mutation frequency of 20.4%. TBK1 was the most important genetic cause of ALS/FTD (n=5; 9.3%). The second most common mutated gene was SQSTM1, with three mutation carriers (one of them also harboured a TBK1 mutation). We also detected probable pathogenic genetic alterations in TAF15, VCP and TARDBP and possible pathogenic mutations in FIG4 and ERBB4.
CONCLUSION: Our results indicate a high genetic burden underlying the co-occurrence of ALS and FTD and expand the phenotype associated with TAF15, FIG4 and ERBB4 to FTD. A systematic screening of ALS and FTD genes could be indicated in patients manifesting both diseases without the C9orf72 expansion mutation, regardless of family history of disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28889094     DOI: 10.1136/jnnp-2017-316820

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

Review 1.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 2.  Genetic modifiers and non-Mendelian aspects of CMT.

Authors:  Dana M Bis-Brewer; Sarah Fazal; Stephan Züchner
Journal:  Brain Res       Date:  2019-09-13       Impact factor: 3.252

Review 3.  Perspectives on the Genomics of HSP Beyond Mendelian Inheritance.

Authors:  Dana M Bis-Brewer; Stephan Züchner
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

4.  A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders.

Authors:  Ruth Lamb; Jonathan D Rohrer; Raquel Real; Steven J Lubbe; Adrian J Waite; Derek J Blake; R Jon Walters; Tammaryn Lashley; Tamas Revesz; Janice L Holton; Huw R Morris
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

5.  The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders.

Authors:  Daniel Alcolea; Jordi Clarimón; María Carmona-Iragui; Ignacio Illán-Gala; Estrella Morenas-Rodríguez; Isabel Barroeta; Roser Ribosa-Nogué; Isabel Sala; M Belén Sánchez-Saudinós; Laura Videla; Andrea Subirana; Bessy Benejam; Sílvia Valldeneu; Susana Fernández; Teresa Estellés; Miren Altuna; Miguel Santos-Santos; Lídia García-Losada; Alexandre Bejanin; Jordi Pegueroles; Víctor Montal; Eduard Vilaplana; Olivia Belbin; Oriol Dols-Icardo; Sònia Sirisi; Marta Querol-Vilaseca; Laura Cervera-Carles; Laia Muñoz; Raúl Núñez; Soraya Torres; M Valle Camacho; Ignasi Carrió; Sandra Giménez; Constance Delaby; Ricard Rojas-Garcia; Janina Turon-Sans; Javier Pagonabarraga; Amanda Jiménez; Rafael Blesa; Juan Fortea; Alberto Lleó
Journal:  Alzheimers Dement (N Y)       Date:  2019-10-14

6.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

Review 7.  The Impact of Kinases in Amyotrophic Lateral Sclerosis at the Neuromuscular Synapse: Insights into BDNF/TrkB and PKC Signaling.

Authors:  Maria A Lanuza; Laia Just-Borràs; Erica Hurtado; Víctor Cilleros-Mañé; Marta Tomàs; Neus Garcia; Josep Tomàs
Journal:  Cells       Date:  2019-12-05       Impact factor: 6.600

Review 8.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

9.  Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.

Authors:  Michael J Keogh; Wei Wei; Juvid Aryaman; Ian Wilson; Kevin Talbot; Martin R Turner; Chris-Anne McKenzie; Claire Troakes; Johannes Attems; Colin Smith; Safa Al Sarraj; Chris M Morris; Olaf Ansorge; Stuart Pickering-Brown; Nick Jones; James W Ironside; Patrick F Chinnery
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-13       Impact factor: 10.154

10.  Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia.

Authors:  Merel O Mol; Tsz H Wong; Shamiram Melhem; Sreya Basu; Riccardo Viscusi; Niels Galjart; Annemieke J M Rozemuller; Claudia Fallini; John E Landers; Laura Donker Kaat; Harro Seelaar; Jeroen G J van Rooij; John C van Swieten
Journal:  Neurol Genet       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.